BEPHAR
Part of the group
13 companies
Board
2 directors, 1 in day-to-day management, last change in 2024Director and managing director, permanent representative
director current term since 14-09-2022
managing director appointed by deed of 06-07-2020
term until 13-09-2028
listed in the 2025 annual accounts, filed on 30-06-2026
Director, permanent representative
current term since 14-09-2022
term until 13-09-2028
listed in the 2025 annual accounts, filed on 30-06-2026
Permanent representatives 2
Mandates through the years
5 names, the dashed line is todayDirector, Managing director
Director
Director
Director
Director
LeadershipBoardEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
-
- Director, from 26-05-2020 to date
- Managing director, appointed by deed of 06-07-2020, still in office
-
- Director, from 26-05-2020 to date
-
- Director, from before 05-08-2014 to 29-11-2024
-
- Director, from before 05-08-2014 to 06-07-2020
-
- Director, from before 05-08-2014 to 06-07-2020
- Managing director, from before 05-08-2014, ended, last mentioned on 05-08-2014
Control
Parent
Equity €23.1m
Profit €2.0m in 2025 (profit €1.9m in 2024)
Checked score
Source: accounts 2025
99.8%
This company
BEPHAR
Equity €165,161
Profit €32,036 in 2025
Capital
- Capital
- €123,947
- Shares
- 500
- Contribution per share
- €248
- Equity per share
- €330 in 2025
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themSource: lists of holdings in the owners' accounts
Articles of association
deed of 12-10-2022 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Seule assemblée générale nomme nouvel administrateur, simple notification au conseil d’administration”
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Moitié cédant moitié cessionnaire(s), dispositions applicables mutatis mutandis aux transmissions pour cause de mort”